Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Use of CRISPR/Cas9-engineered INS-1 pancreatic cells to define the pharmacology of dual GIPR/GLP-1R agonists
Quick Summary Quick Summary The brain releases growth hormonereleasing hormone (GHRH) signals the pituitary to release growth hormone (GH) signals the liver to produce IGF-1
doi: 10.1371/journal.pone.0160221 Summary Keywords GLP-1 receptor agonists, gastrointestinal toxicities, adverse drug reactions, pharmacovigilance, data mining Citation Liu L, Chen J, Wang L, Chen C and Chen L (2022) Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database
In contrast, our study on the basis of several large populations of European descent displayed a significant positive association of genetically predicted vitamin B12 concentrations with NAFLD risk
Sodium butyrate induces ferroptosis in endometrial cancer cells via the RBM3/SLC7A11 axis
